Evidence map›Paper›PMID 28024153›Full record

ArticleNature immunology2017

HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.

Sonja I Gringhuis, Nina Hertoghs, Tanja M Kaptein, Esther M Zijlstra-Willems, Ramin Sarrami-Forooshani, Joris K Sprokholt, Nienke H van Teijlingen, Neeltje A Kootstra, Thijs Booiman, Karel A van Dort and 3 more

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Sterile activation of RNA-sensing pathways in autoimmunity.Journal of molecular cell biology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Sonja I GringhuisDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Nina HertoghsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Tanja M KapteinDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Esther M Zijlstra-WillemsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Ramin Sarrami-ForooshaniDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Joris K SprokholtDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Nienke H van TeijlingenDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Neeltje A KootstraDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Thijs BooimanDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Karel A van DortDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Carla M S RibeiroDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Agata DrewniakDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Teunis B H GeijtenbeekDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
University of Amsterdam · NLAcademic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms by which human immunodeficiency virus 1 (HIV-1) avoids immune surveillance by dendritic cells (DCs), and thereby prevents protective adaptive immune responses, remain poorly understood. Here we showed that HIV-1 actively arrested antiviral immune responses by DCs, which contributed to efficient HIV-1 replication in infected individuals. We identified the RNA helicase DDX3 as an HIV-1 sensor that bound abortive HIV-1 RNA after HIV-1 infection and induced DC maturation and type I interferon responses via the signaling adaptor MAVS. Notably, HIV-1 recognition by the C-type lectin receptor DC-SIGN activated the mitotic kinase PLK1, which suppressed signaling downstream of MAVS, thereby interfering with intrinsic host defense during HIV-1 infection. Finally, we showed that PLK1-mediated suppression of DDX3-MAVS signaling was a viral strategy that accelerated HIV-1 replication in infected individuals.

Indexed as

Immune EvasionImmunityAdaptor Proteins, Signal TransducingCell ExtractsClustered Regularly Interspaced Short Palindromic RepeatsCohort StudiesDEAD-box RNA HelicasesDendritic CellsGene Expression Regulation, ViralHEK293 CellsHIV-1HIV InfectionsHost-Pathogen InteractionsHumansInterferon-betaMacrophagesAdaptor Proteins, Signal TransducingCell ExtractsDDX3X protein, humanDEAD-box RNA HelicasesInterferon-betaMAVS protein, humanReceptors, Pattern RecognitionRNA, Viral

Identifiers

PMID28024153
OpenAlexW2561919277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.